ERS Genomics and genOway enter CRISPR/Cas9 agreement

By | June 7, 2021
ERS Genomics Limited today announced a non-exclusive license agreement granting genOway past and future access to ERS Genomics’ CRISPR/Cas9 patent portfolio.